Search research articles
Contact Us
Filters
Showing results (31-40 of 55) with videos related to
Page
of 6
Sort By:
The Journal of Family Planning and Reproductive Health Care
|
September 25, 2013
Comment on journal review of 'Use of depot medroxyprogesterone acetate contraception and incidence of bone fracture'
Lee L Lanza, Lisa J McQuay, Kenneth J Rothman, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
October 31, 2009
Odanacatib, a cathepsin-K inhibitor for osteoporosis: a two-year study in postmenopausal women with low bone density
Henry G Bone, Michael R McClung, Christian Roux, et al.
Obstetrics and Gynecology
|
May 3, 2013
Use of depot medroxyprogesterone acetate contraception and incidence of bone fracture
Lee L Lanza, Lisa J McQuay, Kenneth J Rothman, et al.
The Journal of Clinical Endocrinology and Metabolism
|
August 14, 2003
Pins and plaster aren't enough: a call for the evaluation and treatment of patients with osteoporotic fractures
Ethel S Siris, John P Bilezikian, Mishaela R Rubin, et al.
Annals of Internal Medicine
|
March 7, 2007
Effect of recombinant human parathyroid hormone (1-84) on vertebral fracture and bone mineral density in postmenopausal women with osteoporosis: a randomized trial
Susan L Greenspan, Henry G Bone, Mark P Ettinger, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
March 10, 2017
Safety Observations With 3 Years of Denosumab Exposure: Comparison Between Subjects Who Received Denosumab During the Randomized FREEDOM Trial and Subjects Who Crossed Over to Denosumab During the FREEDOM Extension
Nelson B Watts, Jacques P Brown, Socrates Papapoulos, et al.
BMC Musculoskeletal Disorders
|
April 29, 2017
Influence of subject discontinuation on long-term nonvertebral fracture rate in the denosumab FREEDOM Extension study
Jonathan D Adachi, Henry G Bone, Nadia S Daizadeh, et al.
The New England Journal of Medicine
|
March 19, 2004
Ten years' experience with alendronate for osteoporosis in postmenopausal women
Henry G Bone, David Hosking, Jean-Pierre Devogelaer, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
April 26, 2018
Effects of 24 Months of Treatment With Romosozumab Followed by 12 Months of Denosumab or Placebo in Postmenopausal Women With Low Bone Mineral Density: A Randomized, Double-Blind, Phase 2, Parallel Group Study
Michael R McClung, Jacques P Brown, Adolfo Diez-Perez, et al.
Calcified Tissue International
|
April 2, 2008
Sequestosome 1 (SQSTM1) mutations in Paget's disease of bone from the United States
Emily C Rhodes, Teresa L Johnson-Pais, Frederick R Singer, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 55) with videos related to
Sort By:
Page
of 6
The Journal of Family Planning and Reproductive Health Care
|
September 25, 2013
Comment on journal review of 'Use of depot medroxyprogesterone acetate contraception and incidence of bone fracture'
Lee L Lanza, Lisa J McQuay, Kenneth J Rothman, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
October 31, 2009
Odanacatib, a cathepsin-K inhibitor for osteoporosis: a two-year study in postmenopausal women with low bone density
Henry G Bone, Michael R McClung, Christian Roux, et al.
Obstetrics and Gynecology
|
May 3, 2013
Use of depot medroxyprogesterone acetate contraception and incidence of bone fracture
Lee L Lanza, Lisa J McQuay, Kenneth J Rothman, et al.
The Journal of Clinical Endocrinology and Metabolism
|
August 14, 2003
Pins and plaster aren't enough: a call for the evaluation and treatment of patients with osteoporotic fractures
Ethel S Siris, John P Bilezikian, Mishaela R Rubin, et al.
Annals of Internal Medicine
|
March 7, 2007
Effect of recombinant human parathyroid hormone (1-84) on vertebral fracture and bone mineral density in postmenopausal women with osteoporosis: a randomized trial
Susan L Greenspan, Henry G Bone, Mark P Ettinger, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
March 10, 2017
Safety Observations With 3 Years of Denosumab Exposure: Comparison Between Subjects Who Received Denosumab During the Randomized FREEDOM Trial and Subjects Who Crossed Over to Denosumab During the FREEDOM Extension
Nelson B Watts, Jacques P Brown, Socrates Papapoulos, et al.
BMC Musculoskeletal Disorders
|
April 29, 2017
Influence of subject discontinuation on long-term nonvertebral fracture rate in the denosumab FREEDOM Extension study
Jonathan D Adachi, Henry G Bone, Nadia S Daizadeh, et al.
The New England Journal of Medicine
|
March 19, 2004
Ten years' experience with alendronate for osteoporosis in postmenopausal women
Henry G Bone, David Hosking, Jean-Pierre Devogelaer, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
April 26, 2018
Effects of 24 Months of Treatment With Romosozumab Followed by 12 Months of Denosumab or Placebo in Postmenopausal Women With Low Bone Mineral Density: A Randomized, Double-Blind, Phase 2, Parallel Group Study
Michael R McClung, Jacques P Brown, Adolfo Diez-Perez, et al.
Calcified Tissue International
|
April 2, 2008
Sequestosome 1 (SQSTM1) mutations in Paget's disease of bone from the United States
Emily C Rhodes, Teresa L Johnson-Pais, Frederick R Singer, et al.
Page
of 6